feed,title,long_url,short_url
SeekingAlpha,Alnylam vutrisiran benefits patients with hATTR Amyloidosis at 18 months in phase 3 study,https://seekingalpha.com/news/3759623,
SeekingAlpha,FFW reports Q3 results,https://seekingalpha.com/news/3759625,
SeekingAlpha,"JAKKS Pacific EPS beats by $0.61, misses on revenue",https://seekingalpha.com/news/3759624,
SeekingAlpha,"iRobot EPS beats by $0.97, beats on revenue",https://seekingalpha.com/news/3759622,
SeekingAlpha,Universal Music Group reports Q3 results,https://seekingalpha.com/news/3759621,
